TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23331510

Group type: EXPERIMENTAL
Intervention: 600,000 IU of Intramuscular vitamin D3
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 21702900

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) - 24 IU intranasal administration
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 17977662

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine 6 mg (total 48 mg over 4 days)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 61
Study: 16671426

Group type: EXPERIMENTAL
Intervention: Surgical treatment (Craniotomy for evacuation)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 530
Study: 12634590

Group type: EXPERIMENTAL
Intervention: Albendazole for 28 days (Group A)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Albendazole for 7 days (Group B)
Number of subjects: 122
Study: 10781452

Group type: EXPERIMENTAL
Intervention: Protocol group (goal-oriented hemodynamic therapy)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 403
Study: 8630614

Group type: EXPERIMENTAL
Intervention: 0.25 mg terbutaline sulphate via Turbuhaler (TBH)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0.25 mg terbutaline sulphate via pMDI
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0.5 mg terbutaline sulphate via pMDI
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.5 mg terbutaline sulphate via Turbuhaler (TBH)
Number of subjects: 13
Study: 1477308

Group type: EXPERIMENTAL
Intervention: 2-mg dose of trihexyphenidyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6398984

Group type: EXPERIMENTAL
Intervention: 1 g Na (44 mmol) daily diet
Number of subjects: 65

Group type: COMPARATOR
Intervention: Reference group (control)
Number of subjects: 65
Study: 3539897

Group type: EXPERIMENTAL
Intervention: Neutron therapy (d(15)+Be neutrons)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Photon therapy (megavoltage photons)
Number of subjects: 0
Study: 29644408

Group type: EXPERIMENTAL
Intervention: Biomarker-driven maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard induction treatment
Number of subjects: 0
Study: 26554630

Group type: EXPERIMENTAL
Intervention: Tapentadol PR 50 mg (titrated to maximum 250 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxycodone/naloxone PR 10 mg/5 mg (titrated to maximum 40 mg/20 mg plus oxycodone PR 10 mg)
Number of subjects: 0
Study: 25689521

Group type: EXPERIMENTAL
Intervention: Low Construal Level (self decision-making)
Number of subjects: 768

Group type: COMPARATOR
Intervention: High Construal Level (advising others)
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Saving 5 people
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Saving 15 people
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Trolley problem
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Footbridge problem
Number of subjects: 768
Study: 23933108

Group type: EXPERIMENTAL
Intervention: Integrated Behavior Therapy for Selective Mutism (IBTSM)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 21
Study: 20462395

Group type: EXPERIMENTAL
Intervention: Topical amphotericin B (0.2 mg/mL) eye drops every 2 hours for 21 days and subconjunctival fluconazole (2 mg/mL) injections
Number of subjects: 12
Study: 18405818

Group type: EXPERIMENTAL
Intervention: Extraction therapy (removal of 4 premolars)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonextraction therapy with air-rotor stripping (ARS)
Number of subjects: 26
Study: 16606473

Group type: EXPERIMENTAL
Intervention: Doxycycline plus streptomycin
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ciprofloxacin plus rifampicin
Number of subjects: 31
Study: 14633755

Group type: EXPERIMENTAL
Intervention: Nefopam (20 mg every 4 h for 24 h)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201

Group type: COMPARATOR
Intervention: Nefopam and Placebo
Number of subjects: 201
Study: 10724301

Group type: EXPERIMENTAL
Intervention: Salbutamol delivered via reservoir DPI (Clickhaler)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salbutamol delivered via conventional pressurized metered-dose inhaler (MDI)
Number of subjects: 0
Study: 8842961

Group type: EXPERIMENTAL
Intervention: Epineurotomy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Nonepineurotomy
Number of subjects: 86
Study: 1523534

Group type: EXPERIMENTAL
Intervention: 0.5% podophyllotoxin cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 60
Study: 6385444

Group type: EXPERIMENTAL
Intervention: 300 mg trimethoprim
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 30712923

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg once daily
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 29086085

Group type: COMPARATOR
Intervention: OnTrack
Number of subjects: 230

Group type: COMPARATOR
Intervention: Onco-Move
Number of subjects: 230
Study: 26825020

Group type: EXPERIMENTAL
Intervention: Portion-Controlled Meals (PCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acceptance-Based Treatment (ABT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 23274083

Group type: EXPERIMENTAL
Intervention: Lamigex (essential oils from Syzygium aromaticum, Lavandula angustifolia, and Geranium robertianum)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ciprofloxacin 0.3%
Number of subjects: 70
Study: 22182296

Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT) plus ongoing routine clinical care (RCC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine Clinical Care (RCC) alone
Number of subjects: 50
Study: 20824976

Group type: EXPERIMENTAL
Intervention: Soybean oil supplementation (20 mL daily) during late pregnancy and first six months of lactation
Number of subjects: 499
Study: 18821156

Group type: EXPERIMENTAL
Intervention: Allopurinol (XO inhibitor)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 15822806

Group type: EXPERIMENTAL
Intervention: Deformable model‐based segmentation of lumen and thrombus using a grey level model and k‐nearest neighbors classification
Number of subjects: 17
Study: 12529568

Group type: EXPERIMENTAL
Intervention: Enhanced interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced programs
Number of subjects: 0
Study: 9642600

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (Group 1) with bupivacaine 0.75% and intravenous midazolam and fentanyl.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (Group 2) with intravenous methohexital followed by retrobulbar block with an equal mixture of lidocaine 2% and bupivacaine 0.75% plus hyaluronidase 150 units.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (Group 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (Group 2)
Number of subjects: 90
Study: 7506007

Group type: EXPERIMENTAL
Intervention: 12-lead electrocardiograms
Number of subjects: 4674

Group type: EXPERIMENTAL
Intervention: 2-minute rhythm strips
Number of subjects: 4674

Group type: EXPERIMENTAL
Intervention: 12-lead ECG
Number of subjects: 4674

Group type: EXPERIMENTAL
Intervention: Serum potassium < 3.5 mmol/L
Number of subjects: 4674
Study: 2554357

Group type: EXPERIMENTAL
Intervention: Synthetic delta sleep‐inducing peptide (DSIP) (25 nmol/kg BW)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Synthetic delta sleep‐inducing peptide (DSIP)
Number of subjects: 11
Study: 351600

Group type: EXPERIMENTAL
Intervention: Fludilat (3 tablets per day for 3 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (same duration as Fludilat)
Number of subjects: 75
Study: 30931761

Group type: EXPERIMENTAL
Intervention: White patient condition
Number of subjects: 57

Group type: COMPARATOR
Intervention: Black patient condition
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 57
Study: 29916929

Group type: EXPERIMENTAL
Intervention: Topical TXA (3 g diluted in 45 mL normal saline, applied after cementation)
Number of subjects: 640

Group type: COMPARATOR
Intervention: IV TXA (1 g prior to tourniquet inflation and 1 g at closure)
Number of subjects: 640
Study: 27476803

Group type: EXPERIMENTAL
Intervention: Supported Employment
Number of subjects: 116
Study: 25501057

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 22252528

Group type: EXPERIMENTAL
Intervention: Brief telephonic program to improve work functioning
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 79
Study: 19463847

Group type: EXPERIMENTAL
Intervention: Regular unspaced sentences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternatingbold unspaced sentences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normally written sentences
Number of subjects: 0
Study: 17258423

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 1.5 mg/kg
Number of subjects: 67
Study: 15153576

Group type: EXPERIMENTAL
Intervention: Control of blood pressure and volume, regulated metabolic and clinical indices
Number of subjects: 155

Group type: COMPARATOR
Intervention: Initial normal LV indices
Number of subjects: 155

Group type: COMPARATOR
Intervention: Initial LV hypertrophy
Number of subjects: 155
Study: 12241831

Group type: EXPERIMENTAL
Intervention: Interventional strategy (angiography followed by revascularisation)
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Conservative strategy (ischaemia-driven or symptom-driven angiography)
Number of subjects: 1810

Group type: EXPERIMENTAL
Intervention: Interventional strategy
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 1810
Study: 9238142

Group type: EXPERIMENTAL
Intervention: Enhanced intervention group (telephone and mail reminders)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Regular intervention group (mail reminder only)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Enhanced intervention for subjects with no postsecondary education
Number of subjects: 256

Group type: COMPARATOR
Intervention: Regular intervention for subjects with higher education
Number of subjects: 256
Study: 7957495

Group type: COMPARATOR
Intervention: HIV-infected patients with CD4 < 200 mm-3 (groups 1 and 2)
Number of subjects: 95

Group type: COMPARATOR
Intervention: HIV-infected patients with CD4 < 400 mm-3 (groups 1, 2, 3)
Number of subjects: 95

Group type: COMPARATOR
Intervention: All HIV-positive patients
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: HIV-positive patients
Number of subjects: 95
Study: 3301980

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (200 mg), administered five times per day for 5 days
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 28857425

Group type: EXPERIMENTAL
Intervention: MCP (30 billion CFUs per sachet, 2 sachets daily for 4 weeks) and omega-3 fatty acid (2 g daily for 8 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 28938980

Group type: EXPERIMENTAL
Intervention: Acupressure to the P6 pressure point using a wristband for a maximum of 2 hours post-surgery.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with malpositioned wristbands.
Number of subjects: 0
Study: 24767875

Group type: EXPERIMENTAL
Intervention: Aspirin (624 mg once daily for 6 months)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (once daily for 6 months)
Number of subjects: 34
Study: 23617712

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 19773525

Group type: EXPERIMENTAL
Intervention: Teduglutide (2.5 to 80 mg, daily subcutaneous administration)
Number of subjects: 256
Study: 17868680

Group type: EXPERIMENTAL
Intervention: Workplace-based physical activity intervention program
Number of subjects: 2929

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2929
Study: 17167156

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity (PA) intervention
Number of subjects: 424

Group type: COMPARATOR
Intervention: Successful aging (SA) health education intervention
Number of subjects: 424
Study: 12881377

Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical examination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of mammography and physical examination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 10761786

Group type: EXPERIMENTAL
Intervention: Elective (immediate) lymph node dissection (ELND)
Number of subjects: 740

Group type: COMPARATOR
Intervention: Nodal observation
Number of subjects: 740
Study: 8826153

Group type: EXPERIMENTAL
Intervention: Biofeedback treatment (10 weekly sessions of 15 minutes' duration)
Number of subjects: 27
Study: 7948812

Group type: EXPERIMENTAL
Intervention: Gastroenterologists
Number of subjects: 313

Group type: COMPARATOR
Intervention: Internists
Number of subjects: 313

Group type: COMPARATOR
Intervention: Gastroenterology nurses
Number of subjects: 313

Group type: COMPARATOR
Intervention: General nurses
Number of subjects: 313

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 313
Study: 3582466

Group type: EXPERIMENTAL
Intervention: Enprofylline (1 mg/kg body weight over 10 min) with terbutaline pretreatment (4 micrograms/kg body weight)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enprofylline (1 mg/kg body weight over 10 min) with placebo pretreatment
Number of subjects: 16
Study: 31518475

Group type: EXPERIMENTAL
Intervention: Flipped classroom method (n=31)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional teaching method (n=30)
Number of subjects: 61
Study: 30289578

Group type: EXPERIMENTAL
Intervention: Tablet-based application (eMedHAT)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Structured interview (MedHAT)
Number of subjects: 220
Study: 28858247

Group type: EXPERIMENTAL
Intervention: Probiotic (10⁸ CFUs of L. reuteri DSM 17938)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24476783

Group type: EXPERIMENTAL
Intervention: Plyometric Training Group (PTG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 22
Study: 22520664

Group type: EXPERIMENTAL
Intervention: Healthy eating counselling
Number of subjects: 23

Group type: COMPARATOR
Intervention: Smoking cessation counselling
Number of subjects: 23
Study: 20718754

Group type: EXPERIMENTAL
Intervention: Aprepitant 40/25mg (40mg on day 1 and 25mg on days 2-5)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Aprepitant 125/80mg (125mg on day 1 and 80mg on days 2-5)
Number of subjects: 453

Group type: COMPARATOR
Intervention: Standard therapy (granisetron and dexamethasone)
Number of subjects: 453
Study: 17716750

Group type: EXPERIMENTAL
Intervention: Treatment group (40 children)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (29 children)
Number of subjects: 73
Study: 15817818

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300‐mg loading dose and 75‐mg maintenance dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12080483

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device (20 microgram/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Thermal balloon ablation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device
Number of subjects: 72
Study: 9882033

Group type: EXPERIMENTAL
Intervention: 20 mg o.m. pantoprazole
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 40 mg o.m. pantoprazole
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 40 mg b.d. pantoprazole
Number of subjects: 64
Study: 7801663

Group type: EXPERIMENTAL
Intervention: Special mechanical device for compression dressing
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conventional pressure dressing
Number of subjects: 500
Study: 2898901

Group type: EXPERIMENTAL
Intervention: 30 micrograms sufentanil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 50 micrograms sufentanil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 75 micrograms sufentanil
Number of subjects: 22

Group type: COMPARATOR
Intervention: No drug (control group IV)
Number of subjects: 22
Study: 31505002

Group type: EXPERIMENTAL
Intervention: Web platform
Number of subjects: 462

Group type: COMPARATOR
Intervention: Genetic counselor
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Both arms (web platform and genetic counselor)
Number of subjects: 462
Study: 29924768

Group type: EXPERIMENTAL
Intervention: Autologous dental pulp mesenchymal stem cells in a collagen matrix
Number of subjects: 32

Group type: COMPARATOR
Intervention: Collagen matrices alone (Control)
Number of subjects: 32
Study: 28739782

Group type: EXPERIMENTAL
Intervention: PZA (10 or 25 mg/kg) plus allopurinol (100 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PZA alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PZA plus allopurinol
Number of subjects: 0
Study: 26650493

Group type: EXPERIMENTAL
Intervention: AMSA injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Supraperiosteal injection
Number of subjects: 30
Study: 23358899

Group type: EXPERIMENTAL
Intervention: 6× hemodialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3× hemodialysis
Number of subjects: 0
Study: 21610860

Group type: EXPERIMENTAL
Intervention: Lifestyle counseling intervention
Number of subjects: 399

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 399
Study: 18477346

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 661

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661
Study: 16507848

Group type: EXPERIMENTAL
Intervention: Montelukast (n=1,439)
Number of subjects: 3073

Group type: EXPERIMENTAL
Intervention: Beclomethasone (n=894)
Number of subjects: 3073

Group type: COMPARATOR
Intervention: Placebo (n=740)
Number of subjects: 3073
Study: 12686231

Group type: EXPERIMENTAL
Intervention: Tecnis Z9000 IOL
Number of subjects: 45

Group type: COMPARATOR
Intervention: SI-40 IOL
Number of subjects: 45
Study: 11093995

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control Group (sterile water)
Number of subjects: 50
Study: 9401313

Group type: EXPERIMENTAL
Intervention: Augmentation therapy with triiodothyronine (T3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Substitution therapy (replacing one antidepressant with another)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (adding a second antidepressant to the first)
Number of subjects: 0
Study: 1420630

Group type: EXPERIMENTAL
Intervention: Marijuana smoking
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo smoking
Number of subjects: 10
Study: 3900457

Group type: EXPERIMENTAL
Intervention: TMS-19-Q.GC tablet (TMS)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Josamycin tablet (JM)
Number of subjects: 154
Study: 31685516

Group type: EXPERIMENTAL
Intervention: Cefazolin plus vancomycin
Number of subjects: 4450

Group type: COMPARATOR
Intervention: Cefazolin plus placebo
Number of subjects: 4450
Study: 30302557

Group type: EXPERIMENTAL
Intervention: Bacterial cellulose wound dressing containing silk sericin and polyhexamethylene biguanide (BCSP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bactigras® (control)
Number of subjects: 21
Study: 27509600

Group type: EXPERIMENTAL
Intervention: Acupuncture method of 'Huoxue Sanfeng, Shugan Jianpi'
Number of subjects: 68

Group type: COMPARATOR
Intervention: Acupuncture method of 'Xingnao Kaiqiao' and oral administration of nifedipine (Control group)
Number of subjects: 68
Study: 24121242

Group type: EXPERIMENTAL
Intervention: Motivational self-talk (ST)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 22669570

Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg in fasted state
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg with light breakfast
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg with high-fat breakfast
Number of subjects: 18
Study: 20925587

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting
Number of subjects: 0
Study: 16934490

Group type: EXPERIMENTAL
Intervention: Judgements of intentions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unpredictable judgement conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control task (reporting time of tones)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deafferented subject IW
Number of subjects: 0
Study: 16274475

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (108 Colony Forming Units daily for 80 days)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri
Number of subjects: 262
Study: 12239690

Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tropisetron 2 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 120
Study: 10519348

Group type: EXPERIMENTAL
Intervention: Early discharge group (EDG) with domiciliary nursing care
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (CG) with standard neonatal care
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Early discharge group (EDG)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Both groups (EDG and CG)
Number of subjects: 88
Study: 10155659

Group type: EXPERIMENTAL
Intervention: Integration of health promotion and health protection through joint worker-management participation, consultation on worksite changes, and educational programs targeting health behavior change.
Number of subjects: 24
Study: 2043298

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 24
Study: 6461999

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine (0.05 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: alcuronium (0.03 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: pancuronium (0.008 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: saline
Number of subjects: 60